Theriva Biologics, Inc. Preferred Stock, Discount on Shares
Theriva Biologics, Inc. (TOVX) had Preferred Stock, Discount on Shares of $400.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockDiscountOnShares · last filed 2019-05-08
- 2019-03-31: Preferred Stock, Discount on Shares $400.00K.
| Period end | Preferred Stock, Discount on Shares |
|---|---|
| 2019-03-31 | $400.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |